Pharmaceutical companies increasingly concentrate on sterile fill-finish services because they must respond to both higher biologics requirements and advancing medical therapies and changing patient needs. The pharmaceutical industry evolves through advancements in sterile production methods along ...

The biopharma industry sees transformation through prediction modeling alongside machine learning which speeds up drug discovery and makes clinical trials more manageable and enables personalized treatment delivery. Large database utilization for decision making enables these technologies to enhanc...

In this editorial, the author has analysed the role of Quantitative structure-activity relationship (QSAR) methods in antidiabetic drug discovery. The author has summarised the trends and has suggested the directions in which QSAR research should focus on the design of novel drugs for diabetes. Int...